article thumbnail

Steris Healthcare announces ₹50 crore expansion and IPO plans for FY 2026–27

Express Pharma

Steris Healthcare, a pharmaceutical company headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627.

article thumbnail

Sun Pharma and Philogen complete patient enrollment for Phase III soft tissue sarcoma trial

Express Pharma

In October 2024, the programme entered a strategic commercial partnership with Sun Pharma, a leading multinational pharmaceutical company. The study is expected to complete enrollment between Q4 2025 and Q1 2026. The soft tissue sarcoma trials are progressing as planned across Europe and the United States. In the U.S.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

Pharmaceutical Commerce

Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV season and avoid past shortages. Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season. 3 References 1. June 9, 2025.

article thumbnail

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.

article thumbnail

Grail plans FDA filing for cancer blood test after new trial

pharmaphorum

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

UK government targets manufacturing as it eyes £41bn life science sector growth

Pharmaceutical Technology

The initiative comes at a crucial time, as British pharmaceutical companies are significantly increasing their investments in the United States. Outlaid via the Life Sciences Innovative Manufacturing Fund (LSMIF), the investment will aim to expand the UK’s manufacturing capabilities and supply chain security.

article thumbnail

Wockhardt has high hopes for novel antibiotic Zaynich

pharmaphorum

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)